Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine oral solution versus tablet in hypothyroid patients receiving chronic proton pump inhibitor therapy
2013-000759-41Phase 4Completed
- Sponsor
- Fondazione Toscana Gabriele Monasterio
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levothyroxine and levothyroxine sodium in hypothyroidism (2 arms), sponsored by Fondazione Toscana Gabriele Monasterio. Primary endpoint: Stable TSH values ranging from 1 to 2 microIU/ml after treatment. Started Aug 2013; status: completed.
02
Drugs
levothyroxinelevothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on 2013-000759-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000759-41.